keyword
MENU ▼
Read by QxMD icon Read
search

Hepatitis C in prison

keyword
https://www.readbyqxmd.com/read/29778259/five-questions-concerning-managing-hepatitis-c-in-the-justice-system-finding-practical-solutions-for-hepatitis-c-virus-elimination
#1
REVIEW
Anne C Spaulding, Madeline G Adee, Robert T Lawrence, Jagpreet Chhatwal, William von Oehsen
An estimated 30% of Americans with hepatitis C virus (HCV) pass through a jail or prison annually. One in 7 incarcerated persons is viremic. Screening and treatment is cost-effective and beneficial to society as a whole. Yet at current (2018) levels of funding for HCV management, prisons are not aggressively seeking cases; few incarcerated persons with HCV actually receive treatment. This article explores barriers to screening for and treating hepatitis C in state prisons, and ways that states may overcome these barriers, such as nominal pricing...
June 2018: Infectious Disease Clinics of North America
https://www.readbyqxmd.com/read/29751763/harm-reduction-and-viral-hepatitis-c-in-european-prisons-a-cross-sectional-survey-of-25-countries
#2
Rob Bielen, Samya R Stumo, Rachel Halford, Klára Werling, Tatjana Reic, Heino Stöver, Geert Robaeys, Jeffrey V Lazarus
BACKGROUND: Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle and syringe programs (NSPs) are effective in preventing the further spread of HCV and HIV, the extent to which these are available in prisons varies significantly across countries. METHODS: The Hep-CORE study surveyed liver patient groups from 25 European countries in 2016 and mid-2017 on national policies related to harm reduction, testing/screening, and treatment for HCV in prison settings...
May 11, 2018: Harm Reduction Journal
https://www.readbyqxmd.com/read/29739400/prevalence-of-hepatitis-c-virus-infection-among-prisoners-in-iran-a-systematic-review-and-meta-analysis
#3
REVIEW
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi
BACKGROUND: Hepatitis C virus (HCV) is one of the major public health problems both in developed and developing countries. Prison represents a high-risk environment for prisoners, in that it is characterized by high-risk behaviors such as injecting drug use (IDU), tattooing, unprotected sexual intercourses, or sharing syringes. The aim of this study was to quantitatively evaluate the prevalence of HCV among Iranian prisoners conducting a systematic review and meta-analysis. METHODS: We searched different scholarly databases including Embase, PubMed/MEDLINE, ISI/Web of Sciences, the Cochrane library, Scopus, CINAHL, and PsycINFO as well as Iranian bibliographic thesauri (namely, Barakatns, MagIran, and SID) up to December 2017...
May 9, 2018: Harm Reduction Journal
https://www.readbyqxmd.com/read/29715590/interventions-to-increase-testing-linkage-to-care-and-treatment-of-hepatitis-c-virus-hcv-infection-among-people-in-prisons-a-systematic-review
#4
REVIEW
Nadine Kronfli, Blake Linthwaite, Fiona Kouyoumdjian, Marina B Klein, Bertrand Lebouché, Giada Sebastiani, Joseph Cox
BACKGROUND: While the burden of chronic hepatitis C virus (HCV) infection is significantly higher among people in prisons compared to the general population, testing and treatment uptake remain suboptimal. The aim of this systematic review was to synthesize evidence on the effectiveness of interventions to increase HCV testing, linkage to care and treatment uptake among people in prisons. METHODS: We searched Medline (Ovid 1996-present), Embase (Ovid 1996-present), and the Cochrane Central Register of Controlled Trials for English language articles published between January 2007 and November 2017...
April 28, 2018: International Journal on Drug Policy
https://www.readbyqxmd.com/read/29698576/prevalence-and-risk-factors-for-hbv-and-hcv-in-prisoners-in-iran-a-national-bio-behavioral-surveillance-survey-in-2015
#5
Ghobad Moradi, Mohammad-Mehdi Gouya, Fatemeh Azimizan, Amjad Mohamadi Bolbanabad, Sonia Darvishi, Mohammad Reza Aghasadeghi, Mahmood Nabavi, Ramin Alasvand, Mehrzad Tashakorian, Bijan Nouri, Khaled Rahmani, Leila Molaei
OBJECTIVES: To provide more accurate estimates of the prevalence of Hepatitis B (HBV) and Hepatitis C (HCV) and their contributing factors among prisoners in Iran. METHODS: Cross-sectional study of 6200 Iranian prisoners in 2015. Data were collected through questionnaires and interviews. HBV infection and HCV exposure status of the participants was determined by HBsAg and HCV antibodies blood tests using Enzyme-Linked Immunosorbent Assay (ELISA). Data were analyzed in STATA-12...
April 26, 2018: Tropical Medicine & International Health: TM & IH
https://www.readbyqxmd.com/read/29688317/hiv-and-viral-hepatitis-among-imprisoned-key-populations
#6
Andrea L Wirtz, Ping T Yeh, Natalie L Flath, Chris Beyrer, Kate Dolan
Prisons and other closed facilities create opportunities for transmission of human immunodeficiency virus (HIV) and viral hepatitis during detention and after release. We conducted a systematic review and meta-analysis of peer-reviewed publications (2005-2015) to describe the prevalence of HIV, hepatitis C virus, and hepatitis B virus among key populations in prisons worldwide and to compare estimates of infection with those of other prison populations. Most data were reported for people who inject drugs (PWID; n = 72) and for men who have sex with men (MSM; n = 21); few data were reported on sex workers (SW; n = 6), or transgender women (n = 2)...
April 21, 2018: Epidemiologic Reviews
https://www.readbyqxmd.com/read/29576049/tattooing-in-prison-a-risk-factor-for-hcv-infection-among-inmates-in-the-quebec-s-provincial-correctional-system
#7
Céline Poulin, Yohann Courtemanche, Bouchra Serhir, Michel Alary
PURPOSE: To determine the prevalence of hepatitis C virus (HCV) and identify related risk factors among inmates in Quebec provincial prisons. METHODS: Anonymous cross-sectional data were collected between May 2014 and March 2015 for 1315 men and 250 women who completed a questionnaire and provided oral fluid samples. RESULTS: The global prevalence of HCV infection was 11.9% in male participants and 19.2% in female participants (P = .003)...
April 2018: Annals of Epidemiology
https://www.readbyqxmd.com/read/29566137/dynamic-models-of-infectious-disease-transmission-in-prisons-and-the-general-population
#8
Martial L Ndeffo-Mbah, Vivian S Vigliotti, Laura A Skrip, Kate Dolan, Alison P Galvani
Incarcerated populations experience elevated burdens of infectious diseases, which are exacerbated by limited access to prevention measures. Dynamic models are used to assess the spread and control of diseases within correctional facilities and repercussions on the general population. Our systematic review of dynamic models of infectious diseases within correctional settings identified 34 studies published between 1996 and 2017. Of these, 23 focused on disease dynamics and intervention in prison without accounting for subsequent spread to the community...
March 16, 2018: Epidemiologic Reviews
https://www.readbyqxmd.com/read/29554240/epidemiology-of-hiv-sexually-transmitted-infections-viral-hepatitis-and-tuberculosis-among-incarcerated-transgender-people-a-case-of-limited-data
#9
Tonia C Poteat, Mannat Malik, Chris Beyrer
Transgender people experience a disproportionate burden of human immunodeficiency virus (HIV) and incarceration. Discrimination, victimization, poverty, and poor mental health drive vulnerability to HIV and related infections, as well as risk of arrest, detention, and incarceration. In this paper, we systematically review published data on HIV, sexually transmitted infections, viral hepatitis, and tuberculosis among incarcerated transgender people; describe potential structural determinants of HIV risk and transmission; identify gaps in the literature; and make recommendations for research and interventions to address this neglected population...
March 15, 2018: Epidemiologic Reviews
https://www.readbyqxmd.com/read/29538639/demonstration-of-near-elimination-of-hepatitis-c-virus-among-a-prison-population-the-lotus-glen-correctional-centre-hepatitis-c-treatment-project
#10
Sofia R Bartlett, Penny Fox, Harris Cabatingan, Anissa Jaros, Carla Gorton, Rhondda Lewis, Eugene Priscott, Gregory J Dore, Darren B Russell
Micro-elimination of hepatitis C virus (HCV) infection through rapid uptake of government-funded direct-acting antiviral (DAA) therapy within an Australian prison setting is demonstrated. During a 22 month period, 119 patients initiated treatment for chronic HCV infection, with HCV in-prison viremic prevalence declining from 12% to 1%.
March 12, 2018: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/29527934/hiv-risk-perception-and-eligibility-for-pre-exposure-prophylaxis-in-women-involved-in-the-criminal-justice-system
#11
Ronnye Rutledge, Lynn Madden, Onyema Ogbuagu, Jaimie P Meyer
Women involved in the criminal justice system (WICJ) are at high risk of acquiring HIV and would benefit from HIV pre-exposure prophylaxis (PrEP) but there are no studies in this population to inform PrEP implementation programs. We conducted a cross-sectional survey of HIV-uninfected, cis-gender women on probation, parole and/or recently released from prison/jail to assess PrEP awareness, eligibility, potential barriers to uptake, and the PrEP care continuum. The 125 WICJ surveyed reported high rates of HIV risk behaviors including recent transactional sex (22...
March 11, 2018: AIDS Care
https://www.readbyqxmd.com/read/29461238/effective-treatment-of-chronic-hepatitis-c-virus-infections-with-direct-acting-antivirals-in-prisons-system
#12
E Vashakidze, T Imnadze, I Mikadze
Hepatitis C is a widespread infectious disorder, accounting for chronic hepatic inflammatory condition - hepatitis, hepatic cirrhosis and hepatocellular carcinoma throughout the world. In Georgia, where the incidence of HCV infection in population is highest among eastern European countries, hepatitis C represents one the most actual problems of healthcare system. The aim of the study was to identify the efficacy of antiviral therapy and management of side effects in HCV infected patients. In the patients under observation with type I genotype, the rapid viral response (RVR) was negative in 100%...
January 2018: Georgian Medical News
https://www.readbyqxmd.com/read/29455713/age-specific-global-prevalence-of-hepatitis-b-hepatitis-c-hiv-and-tuberculosis-among-incarcerated-people-a-systematic-review
#13
REVIEW
Stuart A Kinner, Kathryn Snow, Andrea L Wirtz, Frederick L Altice, Chris Beyrer, Kate Dolan
PURPOSE: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. METHODS: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years)...
March 2018: Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine
https://www.readbyqxmd.com/read/29438397/capacity-of-non-invasive-hepatic-fibrosis-algorithms-to-replace-transient-elastography-to-exclude-cirrhosis-in-people-with-hepatitis-c-virus-infection-a-multi-centre-observational-study
#14
MULTICENTER STUDY
Melissa Louise Kelly, Stephen M Riordan, Rohan Bopage, Andrew R Lloyd, Jeffrey John Post
INTRODUCTION: Achievement of the 2030 World Health Organisation (WHO) global hepatitis C virus (HCV) elimination targets will be underpinned by scale-up of testing and use of direct-acting antiviral treatments. In Australia, despite publically-funded testing and treatment, less than 15% of patients were treated in the first year of treatment access, highlighting the need for greater efficiency of health service delivery. To this end, non-invasive fibrosis algorithms were examined to reduce reliance on transient elastography (TE) which is currently utilised for the assessment of cirrhosis in most Australian clinical settings...
2018: PloS One
https://www.readbyqxmd.com/read/29433454/hepatitis-b-c-in-the-countries-of-the-eu-eea-a-systematic-review-of-the-prevalence-among-at-risk-groups
#15
REVIEW
Abby May Falla, Sanne Henrietta Ina Hofstraat, Erika Duffell, Susan Josien Maria Hahné, Lara Tavoschi, Irene Karen Veldhuijzen
BACKGROUND: In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic Area (EU/EEA) among three at-risk populations: people in prison, men who have sex with men (MSM), and people who inject drugs (PWID). METHODS: Estimates of the prevalence among the three risk groups included in our study were derived from multiple sources...
February 12, 2018: BMC Infectious Diseases
https://www.readbyqxmd.com/read/29389957/genotype-distribution-and-treatment-response-among-incarcerated-drug-dependent-patients-with-chronic-hepatitis-c-infection
#16
Chun-Han Cheng, Ching-Chung Lin, Huan-Lin Chen, I-Tsung Lin, Chia-Hsien Wu, Yuan-Kai Lee, Ming-Jong Bair
The prevalence of hepatitis C virus (HCV) infection is disproportionately high among prisoners, especially among those who are drug-dependent. However, current screening and treatment recommendations are inconsistent for this population, and appropriate care is not reliably provided. To address these problems, the present study aimed to identify unique characteristics and clinical manifestations of incarcerated patients with HCV infection. We included incarcerated patients who received treatment with pegylated-interferon combined with ribavirin at Mackay Memorial Hospital in Taitung and were serving sentences at either the Taiyuan Skill Training Institute or the Yanwan Training Institute...
2018: PloS One
https://www.readbyqxmd.com/read/29386076/outbreak-of-legionnaires-disease-associated-with-cooling-towers-at-a-california-state-prison-2015
#17
K D Lucas, C Wheeler, P McLendon, B N Leistikow, J C Mohle-Boetani
A large outbreak of Legionnaires' disease occurred at a California state prison in August 2015. We conducted environmental and epidemiological investigations to identify the most likely source of exposure and characterise morbidity. Sixty-four inmates had probable Legionnaires' disease; 14 had laboratory-confirmed legionellosis. Thirteen (17%) inmates were hospitalised; there were no deaths. Ill inmates were more likely to be ⩾65 years old (P < 0.01), have the chronic obstructive pulmonary disease (P < 0...
February 2018: Epidemiology and Infection
https://www.readbyqxmd.com/read/29378868/care-for-people-with-hepatitis-c-in-provincial-and-territorial-prisons
#18
Nadine Kronfli, Joseph Cox
No abstract text is available yet for this article.
January 29, 2018: CMAJ: Canadian Medical Association Journal, Journal de L'Association Medicale Canadienne
https://www.readbyqxmd.com/read/29282239/prescribing-opioid-replacement-therapy-in-u-s-correctional-settings
#19
Pantea Farahmand, Vania Modesto-Lowe, Margaret M Chaplin
Opioid addiction is a chronic, relapsing disorder associated with criminality, unemployment, infectious diseases, and legal problems. Such addictions are typically over-represented in correctional populations. Inmates with untreated opioid addiction often relapse shortly after release into the community, thereby increasing the risk of overdose, serious illnesses (HIV, hepatitis C) and psychosocial problems (e.g., crimes, recidivism, and reincarceration). There are three U.S. Food and Drug Administration-approved medications for the treatment of opioid use disorder: methadone, buprenorphine, and naltrexone...
December 2017: Journal of the American Academy of Psychiatry and the Law
https://www.readbyqxmd.com/read/29245104/who-goes-first-understanding-hepatitis-c-risk-among-injecting-networks-in-the-prison-setting
#20
Lise Lafferty, Jake Rance, Carla Treloar
BACKGROUND: Hepatitis C (HCV) is a blood-borne virus that is most commonly transmitted through shared injecting equipment. Due to the criminalisation of injecting drug use, HCV is highly prevalent among those incarcerated. Using a risk environment framework, this qualitative study sought to understand the role of HCV risk within injecting networks in the prison setting. METHODS: Thirty-two adult prisoners (n=24 men; n=8 women) with a history of injecting drug use participated in this qualitative sub-study...
February 1, 2018: Drug and Alcohol Dependence
keyword
keyword
79546
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"